These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 24146388

  • 1. Carbonic anhydrase inhibitors and high altitude illnesses.
    Swenson ER.
    Subcell Biochem; 2014; 75():361-86. PubMed ID: 24146388
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction.
    Swenson ER.
    Respir Physiol Neurobiol; 2006 Apr 28; 151(2-3):209-16. PubMed ID: 16376158
    [Abstract] [Full Text] [Related]

  • 3. Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
    Berger MM, Sareban M, Schiefer LM, Swenson KE, Treff F, Schäfer L, Schmidt P, Schimke MM, Paar M, Niebauer J, Cogo A, Kriemler S, Schwery S, Pickerodt PA, Mayer B, Bärtsch P, Swenson ER.
    J Appl Physiol (1985); 2022 Jun 01; 132(6):1361-1369. PubMed ID: 35511718
    [Abstract] [Full Text] [Related]

  • 4. Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness.
    Leaf DE, Goldfarb DS.
    J Appl Physiol (1985); 2007 Apr 01; 102(4):1313-22. PubMed ID: 17023566
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altitude illness: risk factors, prevention, presentation, and treatment.
    Fiore DC, Hall S, Shoja P.
    Am Fam Physician; 2010 Nov 01; 82(9):1103-10. PubMed ID: 21121556
    [Abstract] [Full Text] [Related]

  • 7. Research advances in pathogenesis and prophylactic measures of acute high altitude illness.
    Li Y, Zhang Y, Zhang Y.
    Respir Med; 2018 Dec 01; 145():145-152. PubMed ID: 30509704
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema.
    Wright A, Brearey S, Imray C.
    Expert Opin Pharmacother; 2008 Jan 01; 9(1):119-27. PubMed ID: 18076343
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Methazolamide in high-altitude illnesses.
    Lu H, Zhang H, Jiang Y.
    Eur J Pharm Sci; 2020 May 30; 148():105326. PubMed ID: 32251722
    [Abstract] [Full Text] [Related]

  • 13. Pharmacology of acute mountain sickness: old drugs and newer thinking.
    Swenson ER.
    J Appl Physiol (1985); 2016 Jan 15; 120(2):204-15. PubMed ID: 26294748
    [Abstract] [Full Text] [Related]

  • 14. Acetazolamide and prevention of acute mountain sickness.
    Prescrire Int; 2014 Nov 15; 23(154):273. PubMed ID: 25954800
    [Abstract] [Full Text] [Related]

  • 15. Altitude, Acute Mountain Sickness, and Acetazolamide: Recommendations for Rapid Ascent.
    Toussaint CM, Kenefick RW, Petrassi FA, Muza SR, Charkoudian N.
    High Alt Med Biol; 2021 Mar 15; 22(1):5-13. PubMed ID: 32975448
    [Abstract] [Full Text] [Related]

  • 16. Acetazolamide for the treatment of acute mountain sickness.
    Tapia L, Irarrázaval S.
    Medwave; 2019 Dec 09; 19(11):e7737. PubMed ID: 31891352
    [Abstract] [Full Text] [Related]

  • 17. High altitude cerebral edema.
    Hackett PH, Roach RC.
    High Alt Med Biol; 2004 Dec 09; 5(2):136-46. PubMed ID: 15265335
    [Abstract] [Full Text] [Related]

  • 18. Acetazolamide for the prevention of acute mountain sickness--a systematic review and meta-analysis.
    Ritchie ND, Baggott AV, Andrew Todd WT.
    J Travel Med; 2012 Dec 09; 19(5):298-307. PubMed ID: 22943270
    [Abstract] [Full Text] [Related]

  • 19. Acetazolamide to Prevent Adverse Altitude Effects in COPD and Healthy Adults.
    Furian M, Mademilov M, Buergin A, Scheiwiller PM, Mayer L, Schneider S, Emilov B, Lichtblau M, Bitos K, Muralt L, Groth A, Reiser AE, Sevik A, Sheraliev U, Marazhapov NH, Aydaralieva S, Muratbekova A, Tabyshova A, Abdraeva A, Buenzli S, Sooronbaev TM, Ulrich S, Bloch KE.
    NEJM Evid; 2022 Jan 09; 1(1):EVIDoa2100006. PubMed ID: 38296630
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.